Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Elosulfase_alfa> ?p ?o }
Showing triples 1 to 46 of
46
with 100 triples per page.
- Elosulfase_alfa abstract "Elosulfase alfa (trade name Vimizim) is a drug for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme.Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration in 2014.".
- Elosulfase_alfa wikiPageID "42240797".
- Elosulfase_alfa wikiPageLength "1882".
- Elosulfase_alfa wikiPageOutDegree "4".
- Elosulfase_alfa wikiPageRevisionID "670214640".
- Elosulfase_alfa wikiPageWikiLink Category:Peptides.
- Elosulfase_alfa wikiPageWikiLink Food_and_Drug_Administration.
- Elosulfase_alfa wikiPageWikiLink Morquio_syndrome.
- Elosulfase_alfa wikiPageWikiLink N-acetylgalactosamine-6-sulfatase.
- Elosulfase_alfa wikiPageWikiLinkText "Elosulfase alfa".
- Elosulfase_alfa wikiPageWikiLinkText "elosulfase alfa".
- Elosulfase_alfa atcPrefix "A16".
- Elosulfase_alfa atcSuffix "AB12".
- Elosulfase_alfa c "5020".
- Elosulfase_alfa casNumber "9025".
- Elosulfase_alfa chemspiderid "NA".
- Elosulfase_alfa h "7588".
- Elosulfase_alfa hasPhotoCollection Elosulfase_alfa.
- Elosulfase_alfa iupharLigand "7392".
- Elosulfase_alfa legalUs "Rx-only".
- Elosulfase_alfa molecularWeight "110.8".
- Elosulfase_alfa n "1364".
- Elosulfase_alfa o "1418".
- Elosulfase_alfa pregnancyUs "C".
- Elosulfase_alfa s "34".
- Elosulfase_alfa tradename "Vimizim".
- Elosulfase_alfa wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Elosulfase_alfa wikiPageUsesTemplate Template:Infobox_drug.
- Elosulfase_alfa wikiPageUsesTemplate Template:Reflist.
- Elosulfase_alfa subject Category:Peptides.
- Elosulfase_alfa hypernym Drug.
- Elosulfase_alfa type ChemicalSubstance.
- Elosulfase_alfa type Drug.
- Elosulfase_alfa type ChemicalObject.
- Elosulfase_alfa type Thing.
- Elosulfase_alfa type Q8386.
- Elosulfase_alfa comment "Elosulfase alfa (trade name Vimizim) is a drug for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme.Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration in 2014.".
- Elosulfase_alfa label "Elosulfase alfa".
- Elosulfase_alfa sameAs Élosulfase_alfa.
- Elosulfase_alfa sameAs エロスルファーゼ_アルファ.
- Elosulfase_alfa sameAs m.0100rzm8.
- Elosulfase_alfa sameAs Элосульфаза_альфа.
- Elosulfase_alfa sameAs Q17119086.
- Elosulfase_alfa sameAs Q17119086.
- Elosulfase_alfa wasDerivedFrom Elosulfase_alfa?oldid=670214640.
- Elosulfase_alfa isPrimaryTopicOf Elosulfase_alfa.